dc.contributor.author | Lu, Lenette L. | |
dc.contributor.author | Smith, Malisa T. | |
dc.contributor.author | Yu, Krystle K. Q. | |
dc.contributor.author | Luedemann, Corinne | |
dc.contributor.author | Suscovich, Todd J. | |
dc.contributor.author | Grace, Patricia S. | |
dc.contributor.author | Cain, Adam | |
dc.contributor.author | Yu, Wen-Han | |
dc.contributor.author | McKitrick, Tanya R. | |
dc.contributor.author | Lauffenburger, Douglas A | |
dc.contributor.author | Cummings, Richard D. | |
dc.contributor.author | Mayanja-Kizza, Harriet | |
dc.contributor.author | Hawn, Thomas R. | |
dc.contributor.author | Boom, W. Henry | |
dc.contributor.author | Stein, Catherine M. | |
dc.contributor.author | Fortune, Sarah M. | |
dc.contributor.author | Seshadri, Chetan | |
dc.contributor.author | Alter, Galit | |
dc.date.accessioned | 2020-06-25T14:49:00Z | |
dc.date.available | 2020-06-25T14:49:00Z | |
dc.date.issued | 2019-05 | |
dc.date.submitted | 2018-11 | |
dc.identifier.issn | 1078-8956 | |
dc.identifier.issn | 1546-170X | |
dc.identifier.uri | https://hdl.handle.net/1721.1/125979 | |
dc.description.abstract | Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is identified using the tuberculin skin test and interferon-γ (IFN-γ) release assay IGRA, and a positive result may prompt chemoprophylaxis to prevent progression to tuberculosis. In the present study, we report on a cohort of Ugandan individuals who were household contacts of patients with TB. These individuals were highly exposed to Mtb but tested negative disease by IFN-γ release assay and tuberculin skin test, ‘resisting’ development of classic LTBI. We show that ‘resisters’ possess IgM, class-switched IgG antibody responses and non-IFN-γ T cell responses to the Mtb-specific proteins ESAT6 and CFP10, immunologic evidence of exposure to Mtb. Compared to subjects with classic LTBI, ‘resisters’ display enhanced antibody avidity and distinct Mtb-specific IgG Fc profiles. These data reveal a distinctive adaptive immune profile among Mtb-exposed subjects, supporting an expanded definition of the host response to Mtb exposure, with implications for public health and the design of clinical trials. | en_US |
dc.description.sponsorship | Bill and Melinda Gates Foundation (Grant OPP1109001) | en_US |
dc.description.sponsorship | Bill and Melinda Gates Foundation (Grant OPP1151840) | en_US |
dc.description.sponsorship | Bill and Melinda Gates Foundation (Grant OPP1156795) | en_US |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1038/s41591-019-0441-3 | en_US |
dc.rights | Creative Commons Attribution 4.0 International license | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Nature | en_US |
dc.title | IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Lu, Lenette L. et al. "IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure." Nature Medicine 25, 6 (May 2019): 977–987 © 2019 The Author(s) | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.relation.journal | Nature Medicine | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2020-03-12T14:27:37Z | |
dspace.date.submission | 2020-03-12T14:27:42Z | |
mit.journal.volume | 25 | en_US |
mit.journal.issue | 6 | en_US |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Complete | |